2017
A patient with central nervous system tuberculomas and a history of disseminated multi-drug-resistant tuberculosis
Kaplan SR, Topal J, Sosa L, Malinis M, Huttner A, Malhotra A, Friedland G. A patient with central nervous system tuberculomas and a history of disseminated multi-drug-resistant tuberculosis. Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases 2017, 10: 9-16. PMID: 31720380, PMCID: PMC6830180, DOI: 10.1016/j.jctube.2017.12.004.Peer-Reviewed Case Reports and Technical NotesDrug-resistant tuberculosisResistant tuberculosisMulti-drug resistant (MDR) TBCentral nervous system tuberculomasCentral nervous system tuberculosisNervous system tuberculosisGlobal public health concernCause of deathIncrease of patientsDrug-resistant strainsPublic health concernExtrapulmonary diseaseMiddle-income countriesNeurological symptomsTreatment challengesTuberculosisHealth concernYoung menPatientsTuberculomaSymptomsDisease
2009
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. The Lancet Infectious Diseases 2009, 9: 153-161. PMID: 19246019, DOI: 10.1016/s1473-3099(09)70041-6.Peer-Reviewed Original ResearchConceptsMultidrug-resistant tuberculosisTreatment outcomesHIV statusTreatment regimensStrong patient supportProportion of patientsPatient's HIV statusTuberculosis treatment programmesHigher treatment successSuccessful treatment outcomePublic health concernStandardised regimensMDR tuberculosisObserved therapyPatient populationTreatment completionTreatment successInclusion criteriaPatient supportTherapeutic studiesClinical reportsTreatment approachesTreatment durationPatientsSystematic review